Miniproteins

We focus on mimicking approaches that do not significantly increase the complexity and size of the inhibitor, thereby excluding strategies such as the grafting of binding epitopes on miniproteins or peptide toxins.[ 1 ] Interactions that are mediated by posttranslational modifications such as phosphorylation or lipidation are also not discussed, as these are mainly driven by the recognition of the modification.